DJCO vs GSK · P/E 5.5, rev $69.2M vs P/E 13, $103.31B cap
Daily Journal Corp (DJCO) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Daily Journal Corp (DJCO) is a software - application company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported DJCO revenue for 2026-06-30 was $69.2M. Net income was -$53.5M. Revenue was up 63.8% from 2026-03-31 to 2026-06-30. DJCO currently screens at market cap $579.2M and trailing P/E 5.5.
GSK does not have a complete income-statement cache yet.
DJCO currently screens at market cap $579.2M and trailing P/E 5.5. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the DJCO and GSK stock pages for the full models.
Not investment advice.